Background: Anew formulation of enteric-coated oral fluoxetine given at a dose of 90mg once weekly has been shown in clinical trials to be well tolerated, safe, effective and associated with very ...

[11] Currently, no commercial liquid or i.v. formulation of esomeprazole is available in the United States; therefore, administering enteric-coated pellets dispersed in water through a nasogastric ...